Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 EUR | +0.63% |
|
-2.45% | -3.64% |
Jun. 06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- News I-Mab
- Transcripts